| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.001 |